These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 9034998)
1. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. Smith MD; Triantafillou S; Parker A; Youssef PP; Coleman M J Rheumatol; 1997 Feb; 24(2):365-71. PubMed ID: 9034998 [TBL] [Abstract][Full Text] [Related]
2. Synovial inflammation in patients with early osteoarthritis of the knee. Myers SL; Brandt KD; Ehlich JW; Braunstein EM; Shelbourne KD; Heck DA; Kalasinski LA J Rheumatol; 1990 Dec; 17(12):1662-9. PubMed ID: 2084242 [TBL] [Abstract][Full Text] [Related]
3. Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblasts. Jovanovic D; Pelletier JP; Alaaeddine N; Mineau F; Geng C; Ranger P; Martel-Pelletier J Osteoarthritis Cartilage; 1998 Jan; 6(1):40-9. PubMed ID: 9616438 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee. Marks PH; Donaldson ML Arthroscopy; 2005 Nov; 21(11):1342-7. PubMed ID: 16325085 [TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183 [TBL] [Abstract][Full Text] [Related]
6. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC; Martel-Pelletier J; Pelletier JP Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286 [TBL] [Abstract][Full Text] [Related]
7. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models. Nixon AJ; Grol MW; Lang HM; Ruan MZC; Stone A; Begum L; Chen Y; Dawson B; Gannon F; Plutizki S; Lee BHL; Guse K Arthritis Rheumatol; 2018 Nov; 70(11):1757-1768. PubMed ID: 30044894 [TBL] [Abstract][Full Text] [Related]
8. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Deleuran BW; Chu CQ; Field M; Brennan FM; Katsikis P; Feldmann M; Maini RN Br J Rheumatol; 1992 Dec; 31(12):801-9. PubMed ID: 1458286 [TBL] [Abstract][Full Text] [Related]
9. Synovial tissue inflammation in early and late osteoarthritis. Benito MJ; Veale DJ; FitzGerald O; van den Berg WB; Bresnihan B Ann Rheum Dis; 2005 Sep; 64(9):1263-7. PubMed ID: 15731292 [TBL] [Abstract][Full Text] [Related]
10. Synovial inflammation in patients with different stages of knee osteoarthritis. Ene R; Sinescu RD; Ene P; Cîrstoiu MM; Cîrstoiu FC Rom J Morphol Embryol; 2015; 56(1):169-73. PubMed ID: 25826502 [TBL] [Abstract][Full Text] [Related]
11. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis. van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963 [TBL] [Abstract][Full Text] [Related]
13. Synovitis in osteoarthritis: current understanding with therapeutic implications. Mathiessen A; Conaghan PG Arthritis Res Ther; 2017 Feb; 19(1):18. PubMed ID: 28148295 [TBL] [Abstract][Full Text] [Related]
14. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression. Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of IL-1 and TNF receptors in inflammatory arthritis and osteoarthritis. Ruggeri R; Pulsatelli L; Melchiorri C; Da Re R; Focherini MC; Veronesi M; Facchini A Boll Soc Ital Biol Sper; 1996; 72(1-2):15-20. PubMed ID: 8868110 [TBL] [Abstract][Full Text] [Related]
17. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints. Weng LH; Ko JY; Wang CJ; Sun YC; Wang FS Arthritis Rheum; 2012 Oct; 64(10):3267-77. PubMed ID: 22736200 [TBL] [Abstract][Full Text] [Related]
18. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Scanzello CR; Umoh E; Pessler F; Diaz-Torne C; Miles T; Dicarlo E; Potter HG; Mandl L; Marx R; Rodeo S; Goldring SR; Crow MK Osteoarthritis Cartilage; 2009 Aug; 17(8):1040-8. PubMed ID: 19289234 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis. Myers SL; Flusser D; Brandt KD; Heck DA J Rheumatol; 1992 Aug; 19(8):1247-51. PubMed ID: 1404161 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J J Rheumatol Suppl; 1995 Feb; 43():109-14. PubMed ID: 7752112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]